Thyroid Cancer Burden Due to High BMI on the Rise in US
Thyroid cancer burden attributable to high BMI was increasing between 1990 and 2021 in the US, especially among men and older adults.
Related Articles
Language evolves — so can you
Nature Reviews Endocrinology – As healthcare professionals, scientists and educators, our intent is to empower people affected by diabetes mellitus; however, if our language is…
Tirzepatide Cardiometabolic Benefits Greater in Women vs Men
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.
Diabetes Medical Management Plan | American Diabetes Association
Ensure standardized and efficient diabetes care in schools with our updated DMMP form. Tailor care instructions for individual students, providing clarity for caregivers.
Welcome! You are invited to join a webinar: From Data to Decisions: Analyzing Automated Insulin Delivery Reports. After registering, you will receive a confirmation email about joining the webinar.
This webinar is designed to assist clinicians, particularly those in primary care, in interpreting the reports generated by automated insulin delivery (AID) systems. Participants will…
Diazoxide Choline Extended-Release Safe for Hyperphagia in Prader-Willi Syndrome
Diazoxide choline extended-release tablets demonstrated favorable safety profile across 4 years among patients with Prader-Willi Syndrome.
Dietas para tireoide valem a pena?
A Dra. Marise Lazaretti, da SBEM Nacional, esclarece atualizações em dietas e tireoide e quais cuidados são necessários antes de seguir qualquer orientação n…
Adolescents With PCOS Show Modest Weight Loss After Bariatric Surgery
Adolescents with PCOS demonstrated comparable weight loss to their reproductively normal peers after undergoing bariatric surgery.
State of Endocrinology
Take this survey powered by surveymonkey.com. Create your own surveys for free.
American Diabetes Association | Research, Education, Advocacy
Leading the fight against the deadly consequences of diabetes for those affected by it through research funding, community services, education and advocacy.
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses…
